In this summary report, we will take a quick look at the top 5 gainers and losers up or down double digits on the Canadian stock markets. Here is…
Search Results for: TRYP.C
Phase 2 I’ve written previously about how expensive clinical trials are, and how not many companies are actually cashed enough to run the trials they plan on. Companies need…
Another busy week in the psychedelic sector, with many smaller companies not always covered here at Equity Guru making news. Let’s start with the biggest players though. Mind Medicine…
Tryp Therapeutics (TRYP.C) announced they plan to conduct a Phase 2a clinical trial with the Chronic Pain & Fatigue Research Center at the University of Michigan Medical School. The study will…
PFN Program Tryp Therapeutics (TRYP.C) is a Kelowna-based psychedelics company looking to improve the lives of those with fibromyalgia, hyperphagia, and eating disorders. In the company’s young life so…